FAS and cancer: Consistent with the effects of fasudil, endocytosis inhibition by 10 μM blebbistatin or 5 μM dyngo-4a markedly increased the signal of Fas microaggregates on cancer cells treated for 2 h, whereas no such increase was observed in HUVECs (Fig. 2d, e).